ANDS

Anadys (ANDS)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANDS
DataOraFonteTitoloSimboloCompagnia
23/11/201122:10Edgar (US Regulatory)(25-NSE)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201120:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201107:39Dow Jones NewsRoche Buys Shares In Tender Offer For Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
16/11/201112:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
14/11/201122:55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
08/11/201114:16MarketwiredAcquisition Spotlight Shines on Hepatitis C Drug DevelopersNASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201123:01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201122:05PR Newswire (US)Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and HighlightsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
04/11/201121:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201114:16MarketwiredPositive Test Results and Acquisitions Drive Shares of Exelixis and Anadys HigherNASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201112:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201123:08Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201122:25Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
24/10/201122:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
21/10/201116:53Business WireThe Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201121:39Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201112:08Dow Jones NewsRoche MS Drug's Good Test Results Boost Pipeline's ProspectsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201101:00Business WireFaruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201123:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201119:12Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201105:30Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201115:00MarketwiredAnalyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LPNASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201102:32Business WireRobbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201101:37Business WireRyan & Maniskas, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201120:42PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys...NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201119:48Business WireTripp Levy PLLC Announces Investigation of Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201117:50ZacksRoche Targets Anadys Pharma - Analyst BlogNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201116:50Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201114:07PR Newswire (US)Anadys Announces Agreement To Be Acquired By RocheNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201107:49Dow Jones NewsRoche To Acquire Anadys Pharmaceuticals, Inc. For $230 MillionNASDAQ:ANDSAnadys Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANDS
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network